Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Analogues of Natural Chalcones as Efficient Inhibitors of AKR1C3.
Metabolites. 2022 Jan 21;12(2):99. doi: 10.3390/metabo12020099.
Metabolites. 2022.
PMID: 35208174
Free PMC article.
Metabolic implication of tigecycline as an efficacious second-line treatment for sorafenib-resistant hepatocellular carcinoma.
Meßner M, Schmitt S, Ardelt MA, Fröhlich T, Müller M, Pein H, Huber-Cantonati P, Ortler C, Koenig LM, Zobel L, Koeberle A, Arnold GJ, Rothenfußer S, Kiemer AK, Gerbes AL, Zischka H, Vollmar AM, Pachmayr J.
Meßner M, et al. Among authors: huber cantonati p.
FASEB J. 2020 Sep;34(9):11860-11882. doi: 10.1096/fj.202001128R. Epub 2020 Jul 11.
FASEB J. 2020.
PMID: 32652772
Item in Clipboard
A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma.
Salcher S, Spoden G, Hagenbuchner J, Führer S, Kaserer T, Tollinger M, Huber-Cantonati P, Gruber T, Schuster D, Gust R, Zwierzina H, Müller T, Kiechl-Kohlendorfer U, Ausserlechner MJ, Obexer P.
Salcher S, et al. Among authors: huber cantonati p.
Oncogene. 2020 Jan;39(5):1080-1097. doi: 10.1038/s41388-019-1044-7. Epub 2019 Oct 7.
Oncogene. 2020.
PMID: 31591479
Free PMC article.
Item in Clipboard
Cite
Cite